SCHEMBL1344576

SCHEMBL1344576

COc1ccc(C2Cc3ccc(OC)cc3C(Cc3ccccc3F)C2C)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
OPRM1 P35372 2/20 0.37
KDM1A O60341 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
HTR2A P28223 1/20 0.36
RORC P51449 2/20 0.36
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
SLC6A4 P31645 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MAPK1 P28482 2/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1346637 0.90 NQO2 (0.46) NQO2MTNR1AMTNR1BOPRM1KDM1A
SCHEMBL1346436 0.89 NQO2 (0.41) NQO2MTNR1AMTNR1BOPRM1KDM1A
SCHEMBL12133263 0.86 KDM1A (0.40) NQO2MTNR1AMTNR1BKDM1AMAOA
SCHEMBL1345970 0.84 NQO2 (0.39) NQO2MTNR1AMTNR1BKDM1AMAOA
SCHEMBL1346410 0.83 SIGMAR1 (0.39) OPRM1MAOBDRD2DRD1OPRD1
SCHEMBL1344331 0.80 NQO2 (0.44) NQO2MTNR1AMTNR1BOPRM1KDM1A
SCHEMBL1346061 0.79 MTNR1A (0.46) NQO2MTNR1AMTNR1BKDM1AMAOA
SCHEMBL1344496 0.78 NQO2 (0.41) NQO2MTNR1AMTNR1BOPRM1KDM1A
SCHEMBL1346915 0.78 NQO2 (0.41) NQO2MTNR1AMTNR1BOPRM1MAOB
SCHEMBL1346589 0.77 NQO2 (0.43) NQO2MTNR1AMTNR1BOPRM1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 NQO2 1888/4885MTNR1A 133/4885MTNR1B 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.